2007
DOI: 10.1590/s1807-59322007000400003
|View full text |Cite
|
Sign up to set email alerts
|

Novel CFTR Missense Mutations in Brazilian Patients With Congenital Absence of Vas Deferens: Counseling Issues.

Abstract: RESULTS:Two novel missense mutations (S753R and G149W) were found in three patients (two brothers) together with the IVS8-5T allele in hetrozygosis. CONCLUSION: The available screenings for CF mutations do not include the atypical mutations associated to absence of vas deferens and thus, when these tests fail to find mutations, there is still a genetic risk of affected children with the help of assisted reproduction. We recommend the screening of the whole CFTR gene for these infertile couples, as part of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2009
2009
2012
2012

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 14 publications
(12 reference statements)
0
3
0
Order By: Relevance
“…In modern molecular medicine, genetic screening is an increasingly useful tool 35 that is currently applied to inherited tumor syndromes such as multiple endocrine neoplasia types 1 36 and 2. 31 …”
Section: Discussionmentioning
confidence: 99%
“…In modern molecular medicine, genetic screening is an increasingly useful tool 35 that is currently applied to inherited tumor syndromes such as multiple endocrine neoplasia types 1 36 and 2. 31 …”
Section: Discussionmentioning
confidence: 99%
“…The frequency of the rest of the mutations varies from one country to another, but their overall frequencies are less than 1%, and could be considered to be rare in Latin America (Pérez et al, 2007). The carrier-rate and mutationfrequencies vary widely in different populations, and so screening tests with high detection-rates for CFTR mutations have to consider the population's ethnicity (Pieri et al, 2007).…”
Section: Considerations For Cf Mutation Screening Testsmentioning
confidence: 99%
“…The atypical CBAVD phenotype, however, is caused by milder mutations, most of them very rare or even not yet described, and thus not included in the panel of CF mutations usually screened. It was proposed that only an extensive CFTR screening can detect rare mutations that are not found by conventional screenings and commercial tests, and can thus improve the diagnosis and care of CF and CAVD as well as the prevention of new cases through the use of reproductive technologies (Pieri et al, 2007).…”
Section: Considerations For Cf Mutation Screening Testsmentioning
confidence: 99%